Search NASA⌕ Search

Engineering topics

Zheng, Liang

Publications and source records attributed to Zheng, Liang.

4 records
All sourcesNASA NTRSDOE OSTI
DOE OSTI2022

Benchmark eA generator for leptoproduction in high-energy lepton-nucleus collisions

The upcoming electron-ion collider (EIC) will address several outstanding puzzles in modern nuclear physics. Topics such as the partonic structure of nucleons and nuclei, the origin of their mass and spin, among others, can be understood via the study of high-energy electron-proton (ep) and electron-nucleus (eA) collisions. Achieving the scientific goals of the EIC will require a novel electron-hadron collider and detectors capable to perform high-precision measurements but also dedicated tools to model and interpret the data. To aid in the latter, we present a general-purpose e A Monte Carlo generator—BeAGLE. In this paper, we provide a general description of the models integrated into BeAGLE, applications of BeAGLE in eA physics, implications for detector requirements at the EIC, and the tuning of the parameters in BeAGLE based on available experimental data. Specifically, we focus on a selection of model and data comparisons in particle production in both ep and eA collisions, where baseline particle distributions provide essential information to characterize the event. In addition, we investigate the collision geometry determination in eA collisions, which could be used as an experimental tool for varying the nuclear density.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗
DOE OSTI2021

Investigation of the background in coherent J/ψ production at the EIC

Understanding various fundamental properties of nucleons and nuclei is among the most important scientific goals at the upcoming Electron-Ion Collider (EIC). With the unprecedented opportunity provided by the next-generation machine, the EIC might provide definitive answers to many standing puzzles and open questions in modern nuclear physics. We investigate one of the golden measurements proposed at the EIC, which is to obtain the spatial gluon density distribution within a lead (Pb) nucleus. The proposed experimental process is the exclusive J/ψ vector-meson production off the Pb nucleus: e + Pb → e' + J/ψ + Pb'. The Fourier transformation of the momentum transfer |t| distribution of the coherent diffraction is the transverse gluon spatial distribution. In order to measure it, the experiment has to overcome an overwhelmingly large background arising from the incoherent diffractive production, where the nucleus Pb' mostly breaks up into fragments of particles in the far-forward direction close to the hadron-going beam rapidity. We systematically study the rejection of incoherent J/ψ production by vetoing products from these nuclear breakups—protons, neutrons, and photons—which is based on the BeAGLE event generator and the most up-to-date EIC Far-forward Interaction Region design. The achieved vetoing efficiency, the ratio between the numbers of vetoed events and total incoherent events, ranges from about 80% to 99% depending on |t|. Assuming a 5% smearing applied to the reconstructed |t| resolution in the Sar t re model, this vetoing efficiency can suppress the incoherent background to at least the first minimum of the coherent |t| distribution. Experimental and accelerator machine challenges as well as potential improvements are discussed herein.

73 NUCLEAR PHYSICS AND RADIATION PHYSICS↗
DOE OSTI2021

CPT2 downregulation triggers stemness and oxaliplatin resistance in colorectal cancer via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism

Highlights: • CPT2 was downregulated in CRC. • CPT2 suppressed the proliferation and glycolytic metabolism in CRC cells. • CPT2 inhibited cancer stem cell properties and oxaliplatin resistance in CRC. • CPT2 attenuated CRC tumor growth and enhanced oxaliplatin sensitivity in vivo. • CPT2 functioned via suppressing ROS/Wnt/β-catenin pathway in CRC. Carnitine palmitoyltransferase 2 (CPT2) has been demonstrated to act as a tumor promotor or suppressor in different types of cancers. However, little is known about the effect of CPT2 on colorectal cancer (CRC). In the present study, we analyzed CPT2 expression in CRC tissues and cells. CPT2 was overexpressed in CRC cell lines (SW480 and RKO), and its effects and molecular mechanism on the proliferation, glycolysis, stemness, and oxaliplatin sensitivity were investigated. The xenograft experiment was used to confirm the influence of CPT2 on CRC tumorigenesis in vivo. We found that CPT2 expression was significantly downregulated in CRC patients, and its lower expression was associated with the poor prognosis, large tumor size, advanced TNM stage, and poor histological grade differentiation of patients. Upregulation of CPT2 significantly inhibited the proliferation, glycolytic metabolism, cancer stem cell properties, and oxaliplatin resistance in CRC cells. Also, the increase of CPT2 inhibited tumorigenesis, stemness and glycolysis, while enhanced oxaliplatin sensitivity in mouse models. Mechanistically, CPT2 functioned via suppressing the activation of Wnt/β-catenin pathway through repressing ROS production. In conclusion, our results demonstrated that CPT2 was decreased in CRC, and CPT2 downregulation could trigger stemness and oxaliplatin resistance in CRC via activating the ROS/Wnt/β-catenin-induced glycolytic metabolism. This study indicates that CPT2 is a potential therapeutic target for CRC.

60 APPLIED LIFE SCIENCES↗